Navigation Links
Collagen VI may help protect the brain against Alzheimer's disease
Date:1/5/2009

SAN FRANCISCO, CA January 5, 2008 Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aβ) proteins, which are widely thought to cause Alzheimer's disease (AD). While the functions of collagens in cartilage and muscle are well established, before this study it was unknown that collagen VI is made by neurons in the brain and that it can fulfill important neuroprotective functions.

The team of investigators led by GIND director Lennart Mucke, MD, reported in the current edition of the journal Nature Neuroscience, that collagen VI is increased in brain tissues of Alzheimer's patients.

"We first noticed the increase in collagen VI in the brain of AD mouse models, which inspired us to look for it in the human condition and to define its role in the disease," said Dr. Mucke.

The Gladstone team had profiled changes in gene expression using DNA microarrays, which provides an unbiased method for identifying key biological pathways. By comparing all of the genes that are active in disease and normal tissue, one can get valuable information on new pathways and potential therapeutic targets.

The researchers looked at the dentate gyrus, a specific area of the brain that is critical to memory and particularly vulnerable in AD, and compared the genes that were turned on and off in normal mice and a mouse model of AD. This analysis revealed the striking increase in collagen VI in the brains of mice that model AD.

Building on this initial finding, the team examined brain tissue from AD patients and normal non-demented humans and found that collagen VI expression was also higher in the AD patients. They further discovered that the cellular source of the collagen VI in the brain was neurons, the very cells that the disease attacks and that we all need to think and remember. <
'/>"/>

Contact: Valerie Tucker
vtucker@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Injectable Collagen Filler Offers Natural Results
2. Galderma Completes Tender Offer for CollaGenex
3. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
4. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
5. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
6. Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material
7. Prenatal Nutrition, Postnatal Allergy Protection
8. To Protect Yourself, Wash Those Germs Away
9. What are protective effects of anti-ricin A-chain aptamer?
10. Exercise Protects Black Women From Type 2 Diabetes
11. Facing Deadly Ice Storms, Home Medical Equipment Providers in New England Mobilize to Protect Oxygen Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... Eva,s Village, ( http://w...i-Poverty Charity, Seeks Buyers for 35mm Michael J...deo. , Paterson, NJ (PRWE...Village.org ), a non-profit New Jersey anti-povert...ic 35mm film print of Michael Jackson,s "Thri...
(Date:7/3/2009)... ReverseAges.com launches ...d pressure, adrenal fatigue, and how to best deal ... San Diego, CA (PRWEB) July 3, 2009 -- ReverseAg.... These pages explain the dangers of common health...essure is caused by a variety of factors, and the ...
(Date:7/3/2009)... Upstate HomeCare, a home ..., specialty medication, respiratory and DME servic... NY have opened. One specializes in home infusion ...line for Upstate HomeCare. , ...HomeCare , a home medical services provider specia...
(Date:7/2/2009)..., AfPA; HAAF Urge State Leaders to Support Princi...AMENTO, Calif., July 2 ...ealth insurance companies have too much influence ...out of five (80%) voters support the concept of a ...e a series of guiding principles for health insura...
Breaking Medicine News(10 mins):Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6
...targets like children's vaccinations. While there ...250,000.// The elevation in GP’s pay is after the ...in as GPs historically earned less than hospital d...becoming a family doctor because of the perceived ...
...s sway to their recommendations on what is good an...food culture. // This attitude has really got unde...e able to digest the ingredients, labeling and mar...ousehold brands. Is that what brand building is a...
...kens have died in a poultry farm in Orissa, but th...have died and the death also has nothing to do wit...try farm at Manari village in Mayurbhanj district,...Samaja said, quoting farm owner Santosh Kumar Pand...
...ith low saturated fat and high fibre content could...Mediterranean diet is a nutritional model inspired...ies of the Mediterranean basin, particularly Italy...omprises high consumption of fruit and vegetables,...
Other Medicine News:Health News:Risk Of Dementia May Be Reduced By Mediterranean Diet 2
(Date:6/30/2009)...30 Calixa Therapeutics Inc. today ...al of CXA-101 in patients with complicated urinary...m, parenteral cephalosporin antibiotic with excell...udomonas aeruginosa , including drug resistant iso...tial treatment for serious bacterial infections in...
(Date:6/29/2009)...y Seeks to Assess RSV Burden in Outpatient Setting... to Pediatric Research , , GAITHERSBURG, Md.,...vance its commitment to pediatric research with to...pective study designed to assess the burden of res...ts 32-to-35 weeks gestational age (GA) in outpatie...
(Date:6/29/2009)...bdominal surgery patients achieved primary and sec... 29 AcelRx Pharmaceuticals, Inc. t...ase 2 clinical study evaluating the safety and eff...e management of acute post-operative pain in patie...ion. Compared to placebo, patients receiving ARX-0...
(Date:6/29/2009)... England, June 29 Vantia Therapeut...g novel, small molecule drugs,targeting large, un...lts from,a Phase IIa clinical trial of its lead d...ial showed that oral VA106483 was successful in pr... effect in patients, as determined by,increased o...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3CHIs 5th Biomarker World Congress 3A Signature Event with Cutting Edge Agenda 7730 1CHIs 5th Biomarker World Congress 3A Signature Event with Cutting Edge Agenda 7730 2CHIs 5th Biomarker World Congress 3A Signature Event with Cutting Edge Agenda 7730 3CHIs 5th Biomarker World Congress 3A Signature Event with Cutting Edge Agenda 7730 4CHIs 5th Biomarker World Congress 3A Signature Event with Cutting Edge Agenda 7730 5Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 1Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 2Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 3Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 4Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 5Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 6Arcadia Completes New Financing 3B Previews Fourth Quarter Results 40850 7Bavarian Nordic Publishes its Annual Results 2008 11254 1Bavarian Nordic Publishes its Annual Results 2008 11254 2Bavarian Nordic Publishes its Annual Results 2008 11254 3Bavarian Nordic Publishes its Annual Results 2008 11254 4Bavarian Nordic Publishes its Annual Results 2008 11254 5Bavarian Nordic Publishes its Annual Results 2008 11254 6Bavarian Nordic Publishes its Annual Results 2008 11254 7What Is It Like to Survive a Plane Crash 3F A Survivor of One of the Worst Small Plane Crashes Tells Her Story 40846 1What Is It Like to Survive a Plane Crash 3F A Survivor of One of the Worst Small Plane Crashes Tells Her Story 40846 2
... 21, 2007 /PRNewswire-FirstCall/ - Biotech,Holding... given,Biotech,s "Sucanon" diabetes drug its suppo...he May-June 2007 issue of Diabetes,Hoy, the Diabet...r,doctors and other health professionals. , The ov...epeda,Gonzalez, Medical Director of the Specialize...
... 21, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM),T...cused on the,treatment of central nervous system d...nnounced that the Company will present data,about ...d its,effect on markers of cardiovascular disease ...s) and insulin-resistance. The,findings come from ...
Other Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3
Codman-Cone Ring Curettes, ring diameter (I.D.) 5 / 16" (8 mm), total length 9" (229 mm).
Hardy Curettes, bayonet, working distance 4 3/4" (120 mm), total length 9 1/2" (241 mm), tip width 3 mm.
PG Magnum Cup Curettes with large capacity cup sizes, total length 12.6" (32 cm) handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm).
Microsect Curette with increased cutting edge and modified shaft, 10".
Medicine Products: